BIOMERIEUX (BIM.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:BIM - FR0013280286 - Common Stock
109.95 EUR
-2.95 (-2.61%)
BIM gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 68 industry peers in the Health Care Equipment & Supplies industry. While BIM has a great health rating, its profitability is only average at the moment. BIM has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
BIM had positive earnings in the past year.
In the past year BIM had a positive cash flow from operations.
In the past 5 years BIM has always been profitable.
Each year in the past 5 years BIM had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 7.04%, BIM is doing good in the industry, outperforming 79.41% of the companies in the same industry.
BIM has a Return On Equity of 9.61%. This is in the better half of the industry: BIM outperforms 61.76% of its industry peers.
With a decent Return On Invested Capital value of 8.56%, BIM is doing good in the industry, outperforming 70.59% of the companies in the same industry.
BIM had an Average Return On Invested Capital over the past 3 years of 10.05%. This is in line with the industry average of 9.73%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.04% | ||
| ROE | 9.61% | ||
| ROIC | 8.56% |
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
1.3 Margins
With a decent Profit Margin value of 9.17%, BIM is doing good in the industry, outperforming 63.24% of the companies in the same industry.
BIM's Profit Margin has been stable in the last couple of years.
BIM's Operating Margin of 12.38% is in line compared to the rest of the industry. BIM outperforms 52.94% of its industry peers.
In the last couple of years the Operating Margin of BIM has grown nicely.
Looking at the Gross Margin, with a value of 56.27%, BIM is in line with its industry, outperforming 52.94% of the companies in the same industry.
BIM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.38% | ||
| PM (TTM) | 9.17% | ||
| GM | 56.27% |
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
2. Health
2.1 Basic Checks
BIM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for BIM remains at a similar level compared to 1 year ago.
Compared to 5 years ago, BIM has less shares outstanding
The debt/assets ratio for BIM has been reduced compared to a year ago.
2.2 Solvency
BIM has an Altman-Z score of 6.99. This indicates that BIM is financially healthy and has little risk of bankruptcy at the moment.
BIM's Altman-Z score of 6.99 is amongst the best of the industry. BIM outperforms 92.65% of its industry peers.
BIM has a debt to FCF ratio of 1.15. This is a very positive value and a sign of high solvency as it would only need 1.15 years to pay back of all of its debts.
The Debt to FCF ratio of BIM (1.15) is better than 85.29% of its industry peers.
A Debt/Equity ratio of 0.09 indicates that BIM is not too dependend on debt financing.
BIM's Debt to Equity ratio of 0.09 is fine compared to the rest of the industry. BIM outperforms 79.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 1.15 | ||
| Altman-Z | 6.99 |
ROIC/WACC1.08
WACC7.92%
2.3 Liquidity
BIM has a Current Ratio of 2.27. This indicates that BIM is financially healthy and has no problem in meeting its short term obligations.
BIM has a Current ratio of 2.27. This is in the better half of the industry: BIM outperforms 66.18% of its industry peers.
A Quick Ratio of 1.30 indicates that BIM should not have too much problems paying its short term obligations.
BIM has a better Quick ratio (1.30) than 61.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.27 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
The earnings per share for BIM have decreased by -8.45% in the last year.
Measured over the past years, BIM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.91% on average per year.
The Revenue has grown by 8.28% in the past year. This is quite good.
Measured over the past years, BIM shows a quite strong growth in Revenue. The Revenue has been growing by 8.27% on average per year.
EPS 1Y (TTM)-8.45%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%
3.2 Future
The Earnings Per Share is expected to grow by 11.79% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.72% on average over the next years.
EPS Next Y16.45%
EPS Next 2Y14.56%
EPS Next 3Y13.42%
EPS Next 5Y11.79%
Revenue Next Year5.19%
Revenue Next 2Y5.72%
Revenue Next 3Y6.1%
Revenue Next 5Y5.72%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 28.48, which means the current valuation is very expensive for BIM.
BIM's Price/Earnings is on the same level as the industry average.
BIM is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 21.71 indicates a rather expensive valuation of BIM.
BIM's Price/Forward Earnings is on the same level as the industry average.
BIM is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.92, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.48 | ||
| Fwd PE | 21.71 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BIM is valued a bit cheaper than the industry average as 69.12% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, BIM is valued a bit cheaper than the industry average as 63.24% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.66 | ||
| EV/EBITDA | 13.67 |
4.3 Compensation for Growth
BIM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BIM has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as BIM's earnings are expected to grow with 13.42% in the coming years.
PEG (NY)1.73
PEG (5Y)2.61
EPS Next 2Y14.56%
EPS Next 3Y13.42%
5. Dividend
5.1 Amount
BIM has a yearly dividend return of 0.79%, which is pretty low.
Compared to an average industry Dividend Yield of 1.13, BIM has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 1.92, BIM's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.79% |
5.2 History
The dividend of BIM is nicely growing with an annual growth rate of 19.40%!
Dividend Growth(5Y)19.4%
Div Incr Years1
Div Non Decr Years7
5.3 Sustainability
BIM pays out 28.07% of its income as dividend. This is a sustainable payout ratio.
The dividend of BIM is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.07%
EPS Next 2Y14.56%
EPS Next 3Y13.42%
EPA:BIM (1/12/2026, 5:29:53 PM)
109.95
-2.95 (-2.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners21.47%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap13.01B
Revenue(TTM)4.12B
Net Income(TTM)378.00M
Analysts75.29
Price Target128.35 (16.73%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.79% |
Yearly Dividend0.85
Dividend Growth(5Y)19.4%
DP28.07%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.62%
PT rev (3m)0.23%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.1%
EPS NY rev (3m)-2.56%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.48 | ||
| Fwd PE | 21.71 | ||
| P/S | 3.16 | ||
| P/FCF | 29.66 | ||
| P/OCF | 16.53 | ||
| P/B | 3.31 | ||
| P/tB | 4.66 | ||
| EV/EBITDA | 13.67 |
EPS(TTM)3.86
EY3.51%
EPS(NY)5.07
Fwd EY4.61%
FCF(TTM)3.71
FCFY3.37%
OCF(TTM)6.65
OCFY6.05%
SpS34.82
BVpS33.24
TBVpS23.61
PEG (NY)1.73
PEG (5Y)2.61
Graham Number53.73
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.04% | ||
| ROE | 9.61% | ||
| ROCE | 11.7% | ||
| ROIC | 8.56% | ||
| ROICexc | 9.38% | ||
| ROICexgc | 13.1% | ||
| OM | 12.38% | ||
| PM (TTM) | 9.17% | ||
| GM | 56.27% | ||
| FCFM | 10.65% |
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
ROICexc(3y)11.26%
ROICexc(5y)13.92%
ROICexgc(3y)17.24%
ROICexgc(5y)22.12%
ROCE(3y)13.71%
ROCE(5y)16.2%
ROICexgc growth 3Y-22.62%
ROICexgc growth 5Y-8.16%
ROICexc growth 3Y-19.11%
ROICexc growth 5Y-1.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
F-Score8
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 1.15 | ||
| Debt/EBITDA | 0.36 | ||
| Cap/Depr | 73.43% | ||
| Cap/Sales | 8.46% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.94% | ||
| Profit Quality | 116.09% | ||
| Current Ratio | 2.27 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 6.99 |
F-Score8
WACC7.92%
ROIC/WACC1.08
Cap/Depr(3y)244.38%
Cap/Depr(5y)271.63%
Cap/Sales(3y)8.63%
Cap/Sales(5y)8.67%
Profit Quality(3y)48.66%
Profit Quality(5y)62.08%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.45%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
EPS Next Y16.45%
EPS Next 2Y14.56%
EPS Next 3Y13.42%
EPS Next 5Y11.79%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%
Revenue Next Year5.19%
Revenue Next 2Y5.72%
Revenue Next 3Y6.1%
Revenue Next 5Y5.72%
EBIT growth 1Y-1.73%
EBIT growth 3Y-7.95%
EBIT growth 5Y10.54%
EBIT Next Year64.69%
EBIT Next 3Y25.44%
EBIT Next 5Y17.89%
FCF growth 1Y133.53%
FCF growth 3Y-15.59%
FCF growth 5Y18.88%
OCF growth 1Y66.81%
OCF growth 3Y-6.82%
OCF growth 5Y10.35%
BIOMERIEUX / BIM.PA FAQ
What is the ChartMill fundamental rating of BIOMERIEUX (BIM.PA) stock?
ChartMill assigns a fundamental rating of 6 / 10 to BIM.PA.
What is the valuation status of BIOMERIEUX (BIM.PA) stock?
ChartMill assigns a valuation rating of 4 / 10 to BIOMERIEUX (BIM.PA). This can be considered as Fairly Valued.
What is the profitability of BIM stock?
BIOMERIEUX (BIM.PA) has a profitability rating of 6 / 10.
Can you provide the financial health for BIM stock?
The financial health rating of BIOMERIEUX (BIM.PA) is 8 / 10.
How sustainable is the dividend of BIOMERIEUX (BIM.PA) stock?
The dividend rating of BIOMERIEUX (BIM.PA) is 3 / 10 and the dividend payout ratio is 28.07%.